Dr. Raphael Hofstein is a life science executive, Past president & CEO of MaRS Innovation. He is a member of the EXCITE Board of Directors and the Advisory Council.
Dr. Hofstein joined MaRS Innovation (now TIAP) in 2009 after past positions that include VP marketing at Ecogen (Bucks County, Pa.), President and CEO of Hadasit (TTO of Hadassah, Jerusalem) and chairman of Hadasit BioHolding (listed on TASE). Dr. Hofstein is a member of several FP and NFP boards and is the chairman of Clinical Trials Ontario.
Dr. Hofstein received his PhD and Master of Science degrees in Life Sciences and Chemistry from the Weizmann Institute of Science in Rehovot, Israel followed by post-doctoral training at Harvard Medical School.
Past president & CEO of MaRS Innovation